As the calendar turns to September, optimistic investors will look for value in quality companies with a history of generating strong revenue and earnings
/PRNewswire/ -- Amgen (NASDAQ:AMGN) and Horizon Therapeutics plc (NASDAQ:HZNP) today announced the entry into a consent order agreement with the Federal Trade...
Pharmaceutical stocks are holding steady as Medicare price negotiations approach, but industry diversification and innovation support future growth prospects.
It looks like the Federal Trade Commission will give up on its attempt to block Amgen's acquisition of Horizon Therapeutics.
Morning Markets September E-Mini S&P 500 futures (ESU2 3) this morning are up +0.45%, and Sep Nasdaq 100 E-Mini futures (NQU2 3) are up +0.59%. Stock indexes this morning are moderately higher on some...
The biotech checks several important boxes for long-term shareholders.
Its pending acquisition of Horizon Therapeutics could make the company much bigger.
A handful of large caps have taken things to another level. These three stocks have blown past the herd — and may be market leaders for years to come.
Morning Markets September E-Mini S&P 500 futures (ESU2 3) this morning are down -0.65%, and Sep Nasdaq 100 E-Mini futures (NQU2 3) are down -0.61%. Stock indexes this morning are moderately lower. Weakness...
Amgen earnings delivered a solid earnings report after the market closed but analyst sentiment suggests that growth may already be priced into AMGN stock.